Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions
Filter
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
FDMT
4D Molecular Therapeutics
Bizily Scott
/
officer: Chief Legal Officer
10/16/2025
Sell
$10.17
1,635
$17K
5,188
NASDAQ
ABEO
Abeona Therapeutics
Seshadri Vishwas
/
director, officer: Chief Executive Officer
10/16/2025
Sell
$5.49
249
$1K
1.19M
NASDAQ
ADMA
ADMA Biologics
Grossman Adam S
/
director, officer: President and CEO
10/24/2025
Sell
$16.00
15,000
$240K
2.03M
NASDAQ
ADMA
ADMA Biologics
Grossman Adam S
/
director, officer: President and CEO
10/24/2025
Sell
$16.00
6,000
$96K
2.02M
NASDAQ
AKRO
Akero Therapeutics
Cheng Andrew
/
director, officer: President and CEO
10/10/2025
Sell
$53.98
30,000
$1.619M
526,114
NASDAQ
ALKS
Alkermes
Hopkinson Craig C.
/
officer: EVP R&D, Chief Medical Officer
10/15/2025
Sell
$31.53
9,000
$284K
73,740
NASDAQ
ALLO
Allogene Therapeutics
Parker Geoffrey M.
/
officer: CHIEF FINANCIAL OFFICER
10/21/2025
Sell
$1.26
36,744
$46K
1.28M
NASDAQ
ALZN
Alzamend Neuro
McGrath Lynne Fahey
/
director
10/23/2025
Sell
$2.29
30
$69
25
NASDAQ
ANGO
AngioDynamics
Weiss Lawrence T
/
officer: SVP, Chief Legal Officer
10/21/2025
Buy
$11.81
10,000
$118K
93,597
NASDAQ
ANIP
ANI Pharmaceuticals
Cook Meredith
/
officer: SR. VP, GENERAL COUNSEL & SEC.
10/13/2025
Sell
$90.09
400
$36K
75,674
NASDAQ
APLS
Apellis Pharmaceuticals
Sullivan Timothy Eugene
/
officer: Chief Financial Officer
10/21/2025
Sell
$28.03
10,000
$280K
110,936
NASDAQ
APLS
Apellis Pharmaceuticals
Watson David O.
/
officer: General Counsel
10/16/2025
Sell
$25.22
5,000
$126K
113,730
NASDAQ
APLS
Apellis Pharmaceuticals
Dunlop A. Sinclair
/
director
10/10/2025
Sell
$23.72
31,092
$738K
3,837
NASDAQ
AQST
Aquestive Therapeutics
Boyd Peter E.
/
officer: See Remarks
10/15/2025
Sell
$7.00
10,000
$70K
268,323
NASDAQ
AQST
Aquestive Therapeutics
Kraus Carl N
/
officer: Chief Medical Officer
10/15/2025
Sell
$7.00
20,272
$142K
282,475
NASDAQ
AQST
Aquestive Therapeutics
Jung Cassie
/
officer: Chief Operating Officer
10/15/2025
Sell
$7.01
67,575
$474K
240,771
NASDAQ
ACLX
Arcellx
Gilson Michelle
/
officer: CHIEF FINANCIAL OFFICER
10/15/2025
Sell
$91.04
5,364
$488K
8,466
NASDAQ
ARTV
Artiva Biotherapeutics
Aslan Fred
/
director, officer: President and CEO
10/17/2025
Sell
$6.00
25,500
$153K
356,721
NASDAQ
AVAH
Aveanna Healthcare
VIGANO PAUL R
/
10 percent owner
10/21/2025
Sell
$9.00
8.35M
$75.115M
20.54M
NASDAQ
AVAH
Aveanna Healthcare
WILLIAMS ROBERT M JR
/
10 percent owner
10/21/2025
Sell
$9.00
156,923
$1.412M
386,284
NASDAQ
AVAH
Aveanna Healthcare
WILLIAMS ROBERT M JR
/
10 percent owner
10/21/2025
Sell
$9.00
1.50M
$13.473M
3.69M
NASDAQ
AVAH
Aveanna Healthcare
WILLIAMS ROBERT M JR
/
10 percent owner
10/21/2025
Sell
$9.00
8.35M
$75.115M
20.54M
NASDAQ
AVAH
Aveanna Healthcare
VIGANO PAUL R
/
10 percent owner
10/21/2025
Sell
$9.00
156,923
$1.412M
386,284
NASDAQ
AVAH
Aveanna Healthcare
J.H. Whitney Equity Partners VII, LLC
/
10 percent owner
10/21/2025
Sell
$9.00
8.35M
$75.115M
20.54M
NASDAQ
AVAH
Aveanna Healthcare
VIGANO PAUL R
/
10 percent owner
10/21/2025
Sell
$9.00
1.50M
$13.473M
3.69M
NASDAQ
RNA
Avidity Biosciences
McCarthy Teresa
/
officer: Chief Human Resources Officer
10/15/2025
Sell
$50.15
20,000
$1.003M
97,130
NASDAQ
RNA
Avidity Biosciences
Hughes Steven George
/
officer: Chief Medical Officer
10/22/2025
Sell
$47.54
2,209
$105K
38,867
NASDAQ
AXGN
Axogen
Burke William P. Mr.
/
director
10/22/2025
Sell
$18.02
1,457
$26K
100
NASDAQ
BYSI
BeyondSpring
Decheng Capital China Life Sciences USD Fund III, L.P.
/
10 percent owner
10/15/2025
Sell
$1.65
17,960
$30K
1.65M
NASDAQ
BYSI
BeyondSpring
Decheng Capital China Life Sciences USD Fund III, L.P.
/
10 percent owner
10/14/2025
Sell
$1.65
28,495
$47K
1.67M
NASDAQ
BYSI
BeyondSpring
Decheng Capital China Life Sciences USD Fund III, L.P.
/
10 percent owner
10/17/2025
Sell
$1.76
45,513
$80K
1.52M
NASDAQ
BYSI
BeyondSpring
Decheng Capital China Life Sciences USD Fund III, L.P.
/
10 percent owner
10/13/2025
Sell
$1.70
107,361
$183K
1.70M
NASDAQ
BYSI
BeyondSpring
Decheng Capital China Life Sciences USD Fund III, L.P.
/
10 percent owner
10/16/2025
Sell
$1.72
85,798
$148K
1.56M
NASDAQ
BLFS
BioLife Solutions
Foster Karen A.
/
officer: Chief Quality and Operations
10/09/2025
Sell
$27.36
419
$11K
193,253
NASDAQ
BLFS
BioLife Solutions
Aebersold Sarah
/
officer: Chief Human Resources Officer
10/09/2025
Sell
$27.36
188
$5K
77,169
NASDAQ
BLFS
BioLife Solutions
DE GREEF RODERICK
/
director, officer: President and CEO
10/22/2025
Sell
$27.30
37,795
$1.032M
489,998
NASDAQ
BLFS
BioLife Solutions
Mathew Aby J.
/
officer: EVP & Chief Scientific Officer
10/09/2025
Sell
$27.36
509
$14K
350,912
NASDAQ
BLFS
BioLife Solutions
Berard Todd
/
officer: Chief Marketing Officer
10/09/2025
Sell
$27.36
289
$8K
133,617
NASDAQ
BLFS
BioLife Solutions
Wichterman Troy
/
officer: Chief Financial Officer
10/09/2025
Sell
$27.36
833
$23K
183,353
NASDAQ
BTSG
BrightSpring Health Services
Nalley Lisa A
/
officer: See Remarks
10/22/2025
Sell
$28.78
20,000
$576K
131,150
NASDAQ
BTSG
BrightSpring Health Services
ROUSSEAU JON B
/
director, officer: See Remarks
10/22/2025
Sell
$28.78
235,000
$6.764M
1.13M
NASDAQ
CSTL
Castle Biosciences
MAETZOLD DEREK J
/
director, officer: Pres. & Chief Exec. Officer
10/20/2025
Sell
$22.44
1,339
$30K
62,988
NASDAQ
CNTA
Centessa Pharmaceuticals
HUSSAIN IQBAL J
/
officer: General Counsel
10/15/2025
Sell
$22.41
6,000
$134K
105,386
NASDAQ
CGON
CG Oncology
POST LEONARD E
/
director
10/13/2025
Sell
$43.25
1,000
$43K
0
NASDAQ
CLOV
Clover Health
Reynoso Jamie L.
/
officer: CEO, Medicare Advantage
10/17/2025
Sell
$2.69
16,514
$44K
2.96M
NASDAQ
CORT
Corcept Therapeutics
Swisher Daniel N JR
/
director
10/10/2025
Sell
$87.54
2,200
$193K
0
NASDAQ
CRSP
CRISPR Therapeutics
Kulkarni Samarth
/
director, officer: Chief Executive Officer
10/17/2025
Sell
$67.91
50,895
$3.456M
254,201
NASDAQ
CGEM
Cullinan Therapeutics
Lynx1 Capital Management LP
/
10 percent owner
10/16/2025
Buy
$8.86
150,000
$1.328M
8.77M
NASDAQ
CGEM
Cullinan Therapeutics
Lynx1 Capital Management LP
/
10 percent owner
10/17/2025
Buy
$7.84
32,217
$253K
8.80M
NASDAQ
CGEM
Cullinan Therapeutics
Lynx1 Capital Management LP
/
10 percent owner
10/14/2025
Buy
$7.59
15,032
$114K
8.56M
NASDAQ
CGEM
Cullinan Therapeutics
Lynx1 Capital Management LP
/
10 percent owner
10/15/2025
Buy
$7.94
51,500
$409K
8.62M
NASDAQ
CYTK
Cytokinetics
Malik Fady Ibraham
/
officer: EVP Research & Development
10/21/2025
Sell
$58.22
2,105
$123K
140,610
NASDAQ
IRON
Disc Medicine
AI DMI LLC
/
10 percent owner
10/22/2025
Sell
$80.47
744,047
$59.873M
2.81M
NYSE
DOCS
Doximity
Benjamin Regina M.
/
director
10/10/2025
Sell
$70.84
5,000
$354K
19,839
NYSE
EBS
Emergent BioSolutions
Glessner Coleen
/
officer: EVP, Quality & Ethics, and CPL
10/07/2025
Sell
$10.00
30,608
$306K
144,319
NASDAQ
ELVN
Enliven Therapeutics
Lyssikatos Joseph P
/
officer: CHIEF SCIENTIFIC OFFICER
10/20/2025
Sell
$22.08
12,500
$276K
915,188
NASDAQ
ELVN
Enliven Therapeutics
Kintz Samuel
/
director, officer: PRESIDENT AND CEO
10/17/2025
Sell
$21.33
12,500
$267K
902,892
NASDAQ
XGN
Exagen
ABALLI JOHN
/
director, officer: President and CEO
10/16/2025
Sell
$11.82
31,787
$376K
714,427
NASDAQ
GALT
Galectin Therapeutics
10X Fund, L.P.
/
10 percent owner
10/22/2025
Sell
$4.94
30,000
$148K
5.87M
NASDAQ
GALT
Galectin Therapeutics
10X Fund, L.P.
/
10 percent owner
10/22/2025
Sell
$4.93
20,000
$99K
5.90M
NASDAQ
GILD
Gilead Sciences
Mercier Johanna
/
officer: Chief Commercial Officer
10/15/2025
Sell
$118.08
3,000
$354K
110,193
NASDAQ
GILD
Gilead Sciences
Dickinson Andrew D
/
officer: Chief Financial Officer
10/15/2025
Sell
$118.08
2,500
$295K
157,055
NASDAQ
GDRX
GoodRx
Spectrum Equity VII, L.P.
/
10 percent owner
10/15/2025
Sell
$4.00
8,569
$34K
0
NASDAQ
GRAL
GRAIL
Ofman Joshua J.
/
officer: President
10/15/2025
Sell
$76.03
8,865
$674K
387,932
NASDAQ
GRAL
GRAIL
RAGUSA ROBERT P
/
director, officer: Chief Executive Officer
10/15/2025
Sell
$68.88
7,239
$499K
727,388
NASDAQ
GRAL
GRAIL
Ofman Joshua J.
/
officer: President
10/16/2025
Sell
$82.01
6,114
$501K
381,818
NASDAQ
GH
Guardant Health
POTTER MYRTLE S
/
director
10/17/2025
Sell
$66.95
26
$2K
18,324
NASDAQ
GH
Guardant Health
Tariq Musa
/
director
10/17/2025
Sell
$66.95
116
$8K
7,725
NASDAQ
HQY
HealthEquity
Ladd Delano
/
officer: EVP, General Counsel
10/20/2025
Sell
$92.07
1,500
$138K
76,979
NASDAQ
HOLX
Hologic
Stamoulis Christiana
/
director
10/20/2025
Sell
$73.07
7,402
$541K
47,336
NASDAQ
INCY
Incyte
Denton Sheila A.
/
officer: EVP & General Counsel
10/15/2025
Sell
$85.13
277
$24K
26,569
NASDAQ
IONS
Ionis Pharmaceuticals
PARSHALL B LYNNE
/
director
10/15/2025
Sell
$71.74
5,000
$359K
61,344
NASDAQ
IONS
Ionis Pharmaceuticals
Swayze Eric
/
officer: EVP Research
10/16/2025
Sell
$73.62
53
$4K
256
NASDAQ
IONS
Ionis Pharmaceuticals
Birchler Brian
/
officer: EVP, Corp and Development Ops
10/15/2025
Sell
$72.23
12,425
$897K
56,826
NASDAQ
IONS
Ionis Pharmaceuticals
Birchler Brian
/
officer: EVP, Corp and Development Ops
10/14/2025
Sell
$72.03
11,475
$827K
56,826
NASDAQ
IONS
Ionis Pharmaceuticals
Devers Shannon L.
/
officer: EVP, Chief Human Resources Ofc
10/15/2025
Sell
$72.94
6,000
$438K
15,937
NASDAQ
IONS
Ionis Pharmaceuticals
Devers Shannon L.
/
officer: EVP, Chief Human Resources Ofc
10/16/2025
Sell
$73.62
1,263
$93K
17,494
NASDAQ
IRMD
IRadimed
Susi Roger E.
/
director, 10 percent owner, officer: CEO, PRESIDENT, CHAIRMAN
10/21/2025
Sell
$75.41
1,423
$107K
2.33M
NASDAQ
IRMD
IRadimed
Susi Roger E.
/
director, 10 percent owner, officer: CEO, PRESIDENT, CHAIRMAN
10/21/2025
Sell
$74.58
3,577
$267K
2.33M
NYSE
JNJ
Johnson & Johnson
REED JOHN C
/
officer: EVP, Innovative Medicine, R&D
10/17/2025
Sell
$192.71
21,721
$4.186M
10,658
NASDAQ
KALA
Kala Bio
Reumuth Mary
/
officer: CHIEF FINANCIAL OFFICER
10/22/2025
Sell
$0.83
32,230
$27K
29,873
NASDAQ
KALA
Kala Bio
Iwicki Mark T
/
director
10/23/2025
Sell
$0.81
154,894
$125K
103,540
NASDAQ
KALA
Kala Bio
Kharabi Darius
/
officer: CHIEF BUSINESS OFFICER
10/22/2025
Sell
$0.83
20,806
$17K
41,760
NASDAQ
KALA
Kala Bio
Brazzell Romulus K
/
officer: SEE REMARKS
10/22/2025
Sell
$0.83
46,748
$39K
35,952
NASDAQ
KALA
Kala Bio
Bazemore Todd
/
director
10/22/2025
Sell
$0.83
47,768
$40K
35,932
NASDAQ
KALA
Kala Bio
Reumuth Mary
/
officer: CHIEF FINANCIAL OFFICER
10/23/2025
Sell
$0.82
967
$793
28,906
NASDAQ
KROS
Keros Therapeutics
ADAR1 Capital Management, LLC
/
10 percent owner
10/15/2025
Sell
$17.75
743,358
$13.195M
0
NASDAQ
KYMR
Kymera Therapeutics
Gollob Jared
/
officer: Chief Medical Officer
10/13/2025
Sell
$60.00
3,114
$187K
118,359
NASDAQ
LVTX
LAVA Therapeutics
Cooperatieve Gilde Healthcare IV U.A.
/
10 percent owner
10/13/2025
Sell
$1.54
47,686
$73K
5.25M
NASDAQ
LVTX
LAVA Therapeutics
Cooperatieve Gilde Healthcare IV U.A.
/
10 percent owner
10/17/2025
Sell
$1.47
1.18M
$1.736M
2.95M
NASDAQ
LVTX
LAVA Therapeutics
Cooperatieve Gilde Healthcare IV U.A.
/
10 percent owner
10/16/2025
Sell
$1.49
690,239
$1.028M
4.13M
NASDAQ
LVTX
LAVA Therapeutics
Cooperatieve Gilde Healthcare IV U.A.
/
10 percent owner
10/14/2025
Sell
$1.51
227,341
$343K
5.02M
NASDAQ
LQDA
Liquidia
Adair Jason
/
officer: Chief Business Officer
10/13/2025
Sell
$23.41
3,670
$86K
175,690
NASDAQ
LQDA
Liquidia
JEFFS ROGER
/
director, officer: Chief Executive Officer
10/13/2025
Sell
$23.41
20,261
$474K
1.03M
NASDAQ
LQDA
Liquidia
Krepp Sarah
/
officer: Chief Human Resource Officer
10/13/2025
Sell
$23.41
1,691
$40K
141,439
OTCMKTS
MRAI
Marpai
Intelligent Fanatics Capital Management LLC
/
10 percent owner
08/19/2025
Sell
$1.40
20,000
$28K
1.79M
OTCMKTS
MRAI
Marpai
Intelligent Fanatics Capital Management LLC
/
10 percent owner
08/18/2025
Sell
$1.40
20,000
$28K
1.81M
OTCMKTS
MRAI
Marpai
Intelligent Fanatics Capital Management LLC
/
10 percent owner
10/06/2025
Sell
$1.63
14,000
$23K
1.77M
OTCMKTS
MRAI
Marpai
Intelligent Fanatics Capital Management LLC
/
10 percent owner
08/20/2025
Sell
$1.42
10,000
$14K
1.78M
NASDAQ
MBX
MBX Biosciences
Hawryluk P. Kent
/
director, officer: President & CEO
10/20/2025
Buy
$13.64
20,000
$273K
468,277
NASDAQ
MBX
MBX Biosciences
Hoerter Steven L.
/
director
10/17/2025
Buy
$13.25
20,000
$265K
20,000
NASDAQ
MGTX
MeiraGTx
Giroux Richard
/
officer: CFO & COO
10/21/2025
Sell
$8.87
24,000
$213K
829,494
NASDAQ
MLYS
Mineralys Therapeutics
Congleton Jon
/
director, officer: Chief Executive Officer
10/13/2025
Sell
$43.03
1,552
$67K
831,305
NASDAQ
MLYS
Mineralys Therapeutics
Congleton Jon
/
director, officer: Chief Executive Officer
10/13/2025
Sell
$42.63
13,548
$578K
832,857
NASDAQ
MLYS
Mineralys Therapeutics
Levy Adam Scott
/
officer: CFO and Secretary
10/13/2025
Sell
$42.26
3,392
$143K
116,865
NASDAQ
MLYS
Mineralys Therapeutics
Levy Adam Scott
/
officer: CFO and Secretary
10/13/2025
Sell
$41.90
7,366
$309K
120,257
NASDAQ
MLYS
Mineralys Therapeutics
Rodman David Malcom
/
officer: Chief Medical Officer
10/15/2025
Sell
$43.01
10,369
$446K
71,155
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
10/17/2025
Sell
$179.35
275
$49K
28,032
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
10/15/2025
Sell
$172.99
153
$26K
239,029
NASDAQ
NTRA
Natera
RABINOWITZ DANIEL
/
officer: SEC. AND CHIEF LEGAL OFFICER
10/21/2025
Sell
$187.95
464
$87K
203,692
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
10/21/2025
Sell
$187.95
93
$17K
236,209
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
10/17/2025
Sell
$178.66
475
$85K
28,307
NASDAQ
NTRA
Natera
Brophy Michael Burkes
/
officer: CHIEF FINANCIAL OFFICER
10/21/2025
Sell
$187.95
602
$113K
70,109
NASDAQ
NTRA
Natera
Rabinowitz Matthew
/
director, officer: EXECUTIVE CHAIRMAN
10/20/2025
Sell
$190.00
10,000
$1.900M
5,000
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
10/17/2025
Sell
$178.58
413
$74K
28,369
NASDAQ
NTRA
Natera
Chapman Steven Leonard
/
director, officer: CEO AND PRESIDENT
10/21/2025
Sell
$187.95
1,603
$301K
155,855
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
10/15/2025
Sell
$176.63
423
$75K
236,112
NASDAQ
NTRA
Natera
Fesko John
/
officer: PRESIDENT, CHIEF BUS. OFFICER
10/21/2025
Sell
$187.95
339
$64K
152,408
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
10/15/2025
Sell
$175.90
988
$174K
236,535
NASDAQ
NTRA
Natera
Moshkevich Solomon
/
officer: PRESIDENT, CLINICALDIAGNOSTICS
10/21/2025
Sell
$187.95
292
$55K
117,267
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
10/17/2025
Sell
$179.29
337
$60K
28,032
NASDAQ
NTRA
Natera
Sheena Jonathan
/
director, other: CO-FOUNDER
10/15/2025
Sell
$175.11
1,506
$264K
237,523
NASDAQ
NEUP
Neuphoria Therapeutics
Lynx1 Capital Management LP
/
10 percent owner
10/21/2025
Buy
$5.14
639,110
$3.283M
875,328
NASDAQ
NUVL
Nuvalent
Pelish Henry E.
/
officer: Chief Scientific Officer
10/13/2025
Sell
$89.81
7,637
$686K
65,963
NASDAQ
NUVL
Nuvalent
Balcom Alexandra
/
officer: Chief Financial Officer
10/14/2025
Sell
$87.67
1,700
$149K
61,934
NASDAQ
NUVL
Nuvalent
Pelish Henry E.
/
officer: Chief Scientific Officer
10/14/2025
Sell
$86.11
866
$75K
66,363
NASDAQ
NUVL
Nuvalent
Balcom Alexandra
/
officer: Chief Financial Officer
10/13/2025
Sell
$88.73
12,266
$1.088M
63,330
NASDAQ
NUVL
Nuvalent
Balcom Alexandra
/
officer: Chief Financial Officer
10/15/2025
Sell
$85.57
1,683
$144K
61,734
NASDAQ
NUVL
Nuvalent
Pelish Henry E.
/
officer: Chief Scientific Officer
10/14/2025
Sell
$84.98
1,167
$99K
67,229
NASDAQ
NUVL
Nuvalent
Balcom Alexandra
/
officer: Chief Financial Officer
10/14/2025
Sell
$86.63
5,820
$504K
63,634
NASDAQ
NUVL
Nuvalent
Pelish Henry E.
/
officer: Chief Scientific Officer
10/15/2025
Sell
$90.04
14,205
$1.279M
65,963
NASDAQ
NUVL
Nuvalent
Balcom Alexandra
/
officer: Chief Financial Officer
10/14/2025
Sell
$85.75
12,280
$1.053M
69,454
NASDAQ
NUVL
Nuvalent
Balcom Alexandra
/
officer: Chief Financial Officer
10/14/2025
Sell
$88.90
200
$18K
61,734
NASDAQ
NUVL
Nuvalent
Balcom Alexandra
/
officer: Chief Financial Officer
10/13/2025
Sell
$87.90
6,138
$540K
75,596
NASDAQ
NUVL
Nuvalent
Pelish Henry E.
/
officer: Chief Scientific Officer
10/14/2025
Sell
$87.39
400
$35K
65,963
NASDAQ
NUVL
Nuvalent
Balcom Alexandra
/
officer: Chief Financial Officer
10/13/2025
Sell
$89.22
1,596
$142K
61,734
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
10/23/2025
Sell
$40.18
3,520
$141K
58,520
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
10/20/2025
Sell
$40.38
16,075
$649K
23,899
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
10/17/2025
Sell
$40.03
700
$28K
39,974
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
10/22/2025
Sell
$40.27
11,859
$478K
62,040
NASDAQ
PAHC
Phibro Animal Health
BENDHEIM JACK
/
director, 10 percent owner, officer: President and CEO
10/24/2025
Sell
$41.75
3,520
$147K
55,000
NYSE
PHR
Phreesia
Hui Yvonne
/
officer: Principal Accounting Officer
10/15/2025
Sell
$23.05
302
$7K
30,336
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$91.04
447
$41K
2.36M
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$130.10
1,661
$216K
2.08M
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$90.00
12,600
$1.134M
2.36M
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$104.31
250,000
$26.077M
2.08M
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$101.00
27,287
$2.756M
2.33M
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$140.00
19,198
$2.688M
2.06M
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$100.11
559
$56K
2.36M
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$92.03
1,363
$125K
2.36M
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$132.19
308
$41K
2.08M
NASDAQ
PRAX
Praxis Precision Medicines
Adage Capital Management, L.P.
/
10 percent owner
10/16/2025
Buy
$131.64
487
$64K
2.08M
NYSE
DGX
Quest Diagnostics
PFEIFFER GARY M
/
director
10/22/2025
Sell
$182.40
1,482
$270K
29,431
NASDAQ
RANI
Rani Therapeutics
South Cone Investments Limited Partnership
/
10 percent owner
10/21/2025
Sell
$2.77
4.00M
$11.074M
2.38M
NASDAQ
RANI
Rani Therapeutics
South Cone Investments Limited Partnership
/
10 percent owner
10/20/2025
Sell
$2.41
1.92M
$4.637M
6.38M
NASDAQ
RAPP
Rapport Therapeutics
Ceesay Abraham
/
director, officer: Chief Executive Officer
10/15/2025
Sell
$25.72
4,647
$120K
580,765
NASDAQ
RAPP
Rapport Therapeutics
Bredt David
/
officer: Chief Scientific Officer
10/15/2025
Sell
$26.16
1,082
$28K
409,642
NASDAQ
RAPP
Rapport Therapeutics
Bredt David
/
officer: Chief Scientific Officer
10/15/2025
Sell
$25.73
7,418
$191K
410,724
NASDAQ
RAPP
Rapport Therapeutics
Ceesay Abraham
/
director, officer: Chief Executive Officer
10/15/2025
Sell
$26.17
755
$20K
41,061
NASDAQ
RAPP
Rapport Therapeutics
Ceesay Abraham
/
director, officer: Chief Executive Officer
10/15/2025
Sell
$25.75
4,328
$111K
41,816
NASDAQ
RAPP
Rapport Therapeutics
Ceesay Abraham
/
director, officer: Chief Executive Officer
10/15/2025
Sell
$26.14
1,186
$31K
579,579
NASDAQ
RXRX
Recursion
Gibson Christopher
/
director, officer: Chief Executive Officer
10/23/2025
Sell
$5.70
100,000
$570K
954,229
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
10/14/2025
Buy
$0.93
14,204
$13K
15.72M
NYSEAMEX
RVP
Retractable Technologies
SHAW THOMAS J
/
director, 10 percent owner, officer: PRESIDENT AND CEO
10/22/2025
Buy
$0.96
10,000
$10K
15.73M
NASDAQ
ROIV
Roivant
Venker Eric
/
officer: President & Immunovant CEO
10/17/2025
Sell
$17.06
118,418
$2.020M
1.50M
NASDAQ
ROIV
Roivant
Venker Eric
/
officer: President & Immunovant CEO
10/16/2025
Sell
$17.05
318,282
$5.427M
1.50M
NASDAQ
ROIV
Roivant
Venker Eric
/
officer: President & Immunovant CEO
10/13/2025
Sell
$16.25
20,727
$337K
1.50M
NASDAQ
ROIV
Roivant
Venker Eric
/
officer: President & Immunovant CEO
10/15/2025
Sell
$16.93
414,683
$7.021M
1.50M
NASDAQ
ROIV
Roivant
Venker Eric
/
officer: President & Immunovant CEO
10/09/2025
Sell
$16.30
104,940
$1.711M
1.50M
NASDAQ
SDGR
Schrodinger
Dugan Margaret
/
officer: Chief Medical Officer
10/16/2025
Sell
$21.07
1,395
$29K
24,574
NYSEAMEX
SER
Serina Therapeutics
Moreadith Randall
/
officer: Chief Scientific Officer
10/20/2025
Sell
$4.97
6,500
$32K
0
NASDAQ
SLDB
Solid Biosciences
Brooks Gabriel
/
officer: Chief Medical Officer
10/20/2025
Sell
$5.96
2,895
$17K
33,819
NASDAQ
SMMT
Summit Therapeutics
Xia Yu
/
director
10/21/2025
Buy
$18.74
533,617
$10.000M
32.06M
NASDAQ
SMMT
Summit Therapeutics
Zanganeh Mahkam
/
director, 10 percent owner, officer: Co-Chief Executive Officer
10/21/2025
Buy
$18.74
26,680
$500K
76,680
NASDAQ
SMMT
Summit Therapeutics
DUGGAN ROBERT W
/
director, 10 percent owner, officer: Co-Chief Executive Officer
10/21/2025
Buy
$18.74
26,680
$500K
76,680
NASDAQ
STRO
Sutro Biopharma
Chung Jane
/
director, officer: Chief Executive Officer
10/15/2025
Buy
$0.80
12,500
$10K
122,850
NASDAQ
STRO
Sutro Biopharma
Chow Gregory K.
/
officer: CFO
10/15/2025
Buy
$0.81
19,750
$16K
19,750
NASDAQ
STRO
Sutro Biopharma
Gerber Hans-Peter
/
officer: CHIEF SCIENTIFIC OFFICER
10/15/2025
Buy
$0.80
17,000
$14K
71,832
NASDAQ
STRO
Sutro Biopharma
Pauling David
/
officer: Chief Admin. Ofcr. & GC
10/15/2025
Buy
$0.80
12,504
$10K
71,737
NASDAQ
STRO
Sutro Biopharma
MATSUI CONNIE
/
director
10/15/2025
Buy
$0.80
50,000
$40K
50,000
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/16/2025
Sell
$431.51
1,654
$714K
976
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/14/2025
Sell
$441.26
2,000
$883K
130
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
10/16/2025
Sell
$432.59
2,078
$899K
39,232
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/15/2025
Sell
$434.80
1,000
$435K
2,130
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/13/2025
Sell
$441.40
3,000
$1.324M
130
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
10/16/2025
Sell
$431.72
2,516
$1.086M
41,310
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/16/2025
Sell
$430.23
1,500
$645K
2,630
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/20/2025
Sell
$422.30
200
$84K
2,331
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/20/2025
Sell
$421.04
1,599
$673K
2,531
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/15/2025
Sell
$433.42
1,000
$433K
3,130
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/14/2025
Sell
$434.01
1,478
$641K
2,130
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
10/16/2025
Sell
$430.59
955
$411K
43,826
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/15/2025
Sell
$436.47
2,000
$873K
130
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/13/2025
Sell
$437.53
1,000
$438K
3,130
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
10/16/2025
Sell
$429.61
1,092
$469K
44,781
NASDAQ
UTHR
United Therapeutics
BENKOWITZ MICHAEL
/
officer: PRESIDENT AND COO
10/13/2025
Sell
$440.35
7,875
$3.468M
0
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
10/16/2025
Sell
$435.42
1
$435
36,781
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/16/2025
Sell
$432.86
846
$366K
130
NASDAQ
UTHR
United Therapeutics
ROTHBLATT MARTINE A
/
director, officer: Chairperson & CEO
10/14/2025
Sell
$432.74
522
$226K
3,608
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
10/16/2025
Sell
$434.76
798
$347K
36,782
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
10/16/2025
Sell
$428.51
1,908
$818K
45,873
NASDAQ
UTHR
United Therapeutics
MAHON PAUL A
/
officer: EVP & GENERAL COUNSEL
10/16/2025
Sell
$433.45
1,652
$716K
37,580
NASDAQ
VIR
Vir Biotechnology
SVF Endurance (Cayman) Ltd
/
10 percent owner
10/22/2025
Sell
$6.15
144,266
$888K
14.87M
NASDAQ
VIR
Vir Biotechnology
SVF Endurance (Cayman) Ltd
/
10 percent owner
10/21/2025
Sell
$6.30
109,675
$691K
15.01M
NASDAQ
VIR
Vir Biotechnology
SVF Endurance (Cayman) Ltd
/
10 percent owner
10/16/2025
Sell
$6.10
12,844
$78K
15.34M
NASDAQ
VIR
Vir Biotechnology
SVF Endurance (Cayman) Ltd
/
10 percent owner
10/20/2025
Sell
$6.20
220,535
$1.367M
15.12M
NASDAQ
VIR
Vir Biotechnology
SVF Endurance (Cayman) Ltd
/
10 percent owner
10/23/2025
Sell
$5.99
154,383
$925K
14.71M
NASDAQ
VIR
Vir Biotechnology
SVF Endurance (Cayman) Ltd
/
10 percent owner
10/15/2025
Sell
$6.07
16,671
$101K
15.35M
NASDAQ
VANI
Vivani Medical
Williams Gregg
/
director, 10 percent owner:
10/15/2025
Buy
$1.12
1.47M
$1.650M
17.38M
NASDAQ
VANI
Vivani Medical
Williams Gregg
/
director, 10 percent owner:
10/15/2025
Buy
$1.26
264,550
$333K
17.65M
NYSEAMEX
VNRX
VolitionRx
Innes Guy Archibald
/
director
10/14/2025
Buy
$0.51
96,153
$49K
1.06M
NYSEAMEX
VNRX
VolitionRx
Reynolds Cameron John
/
director, officer: President and CEO
10/14/2025
Buy
$0.60
110,000
$66K
110,000
NYSEAMEX
VNRX
VolitionRx
Reynolds Cameron John
/
director, officer: President and CEO
10/14/2025
Buy
$0.51
110,000
$56K
2.53M
NYSEAMEX
VNRX
VolitionRx
STILL TIMOTHY I
/
director
10/14/2025
Buy
$0.60
48,076
$29K
48,076
NYSEAMEX
VNRX
VolitionRx
STILL TIMOTHY I
/
director
10/14/2025
Buy
$0.51
48,076
$25K
1.54M
NYSEAMEX
VNRX
VolitionRx
Innes Guy Archibald
/
director
10/14/2025
Buy
$0.60
96,153
$58K
96,153
NASDAQ
VOR
Vor Bio
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
10/20/2025
Sell
$29.63
70,366
$2.085M
1.43M
NASDAQ
VOR
Vor Bio
Reprogrammed Interchange LLC
/
10 percent owner
10/17/2025
Sell
$30.22
24,689
$746K
1.18M
NASDAQ
VOR
Vor Bio
Reprogrammed Interchange LLC
/
10 percent owner
10/14/2025
Sell
$30.32
33,668
$1.021M
1.28M
NASDAQ
VOR
Vor Bio
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
10/20/2025
Sell
$30.12
1,287
$39K
0
NASDAQ
VOR
Vor Bio
Reprogrammed Interchange LLC
/
10 percent owner
10/13/2025
Sell
$33.09
2,334
$77K
1.31M
NASDAQ
VOR
Vor Bio
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
10/20/2025
Sell
$29.63
13,817
$409K
1,287
NASDAQ
VOR
Vor Bio
Reprogrammed Interchange LLC
/
10 percent owner
10/13/2025
Sell
$32.36
19,672
$637K
1.31M
NASDAQ
VOR
Vor Bio
Reprogrammed Interchange LLC
/
10 percent owner
10/10/2025
Sell
$30.97
40,983
$1.269M
1.33M
NASDAQ
VOR
Vor Bio
Reprogrammed Interchange LLC
/
10 percent owner
10/21/2025
Sell
$30.08
200
$6K
1.17M
NASDAQ
VOR
Vor Bio
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
10/21/2025
Sell
$28.11
25,027
$704K
1.40M
NASDAQ
VOR
Vor Bio
Reprogrammed Interchange LLC
/
10 percent owner
10/20/2025
Sell
$30.05
11,616
$349K
1.17M
NASDAQ
VOR
Vor Bio
RA CAPITAL MANAGEMENT, L.P.
/
director, 10 percent owner:
10/20/2025
Sell
$30.12
6,553
$197K
1.43M
NASDAQ
VOR
Vor Bio
Reprogrammed Interchange LLC
/
10 percent owner
10/17/2025
Sell
$31.00
1,028
$32K
1.18M
NASDAQ
WAY
Waystar
Sinclair III Eric L. (Ric)
/
officer: Chief Business Officer
10/20/2025
Sell
$36.94
9,701
$358K
474,826
NASDAQ
ZBIO
Zenas BioPharma
SR ONE CAPITAL MANAGEMENT, LLC
/
10 percent owner
10/09/2025
Buy
$19.00
63,158
$1.200M
1.17M
NASDAQ
ZBIO
Zenas BioPharma
SR ONE CAPITAL MANAGEMENT, LLC
/
10 percent owner
10/09/2025
Buy
$19.00
63,157
$1.200M
1.92M
NASDAQ
ZBIO
Zenas BioPharma
Nunn Jason Raleigh
/
director
10/09/2025
Buy
$19.00
63,158
$1.200M
1.17M
OTCMKTS
ZIVO
ZIVO Bioscience
YALDOO LAITH L
/
director, 10 percent owner:
10/10/2025
Buy
$12.05
1,659
$20K
575,095
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.
